Individual reports for 900,000 participants available from December
Personalised genomic reports will become available to 900,000 participants in the Emirati Genome Program from December, as the UAE moves towards using its population database to inform individual healthcare.
The reports form part of the 2026–2031 National Genomics Masterplan, approved at an Emirates Genome Council meeting on 10 November. The programme now has 1m participants, providing the foundation for wider use of genetic information in preventive care.
Participants will access their reports through the TAMM government services platform. They contain information about 214 inherited genomic conditions and health traits, with guidance to help people understand their results and identify appropriate next steps. The initiative aims to make information about genetic predisposition available directly to individuals, supporting earlier intervention where appropriate.
The masterplan also sets an ambition to extend access to genome sequencing and genomic analysis to all Emirati citizens. Findings will help inform personalised healthcare services based on an individual’s genetic profile, taking the programme beyond the collection of genomic information into its application in care.
Sheikh Khaled bin Mohamed bin Zayed, Crown Prince of Abu Dhabi, approved the plan during the UAE Government Annual Meetings. The council reviewed the programme’s progress alongside preparations for the release of individual reports. The new phase places greater emphasis on translating the national sequencing programme into clinical use, with prevention a central objective.
For Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health – Abu Dhabi and Secretary General of the Emirates Genome Council, the reports give participants access to findings previously concentrated in research. “Providing personalised genomic reports marks a key milestone in this shift,” he says. “The Emirati Genome Program’s unprecedented genomic database allows us to combine data with an AI-powered healthcare system and a state-of-the-art regulatory ecosystem to shift from genomic sequencing toward community-wide prevention and precision medicine.”
A further strand of the plan expands newborn genetic screening nationwide. The screening programme covers more than 730 genes associated with around 815 childhood genetic conditions for which early treatment or clinical intervention is available. Its purpose is to enable diagnosis within the first weeks of life, allowing care to begin earlier.
Research infrastructure is also included in the masterplan through further development of the Trusted Research Environment. It provides a secure digital setting for research using artificial intelligence to analyse data and support precision medicine applications. The environment is intended to support work involving UAE institutions and international research partners, alongside the wider introduction of genomics into healthcare services.
The masterplan supports the UAE’s ambition to use genomic insights and AI to make healthcare more preventive and tailored to individual needs. It aims to help citizens live longer, healthier lives while strengthening the country’s contribution to international healthcare research.
Have some thoughts on the topic? Share them with the community here